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In Hospital Atrial Fibrillation is a Predictor of Long 
Term Stroke Event among Patients with Acute 
Myocardial Infarction
Manoefris Kasim, Octavia Lilyasari, Yoga Yuniadi
Background. Atrial fibrillation (AF) is a common arrhythmia after acute 
myocardial infarction (AMI).Mortality in AMI patients with AF also been 
shown to be up to twice as high as for those without AF. Nonhemorrhagic 
stroke occurs in 0.1% to 1.3%of patients with acute myocardial infarction 
who are treatedwith thrombolytic, with substantial associated mortality 
andmorbidity. The aim of this study is toelaborate correlation between in 
hospital AF with long term stroke event inST-elevation myocardial infarction 
(STEMI) patients who treated with thrombolytic .
Methods. Two hundred and thirty STEMI patients (27-72 yo) treated with 
thrombolytic agent were studied retrospectively. The study end point was 
Major Cardio-Cerebrovascular Event (MACCE) during 3 years follow up. 
Results. Eleven patients experience AF episode during STEMI 
hospitalization. During 3 years follow up 24 patients (10.4%) experienced 
MACCE which comprised of : cardiac death 4 (1.7%), fatal infarction 2 
(0.9%), non fatal infarction 13 (5.7%) and stroke 5 (2.2%). Independent 
clinical variables were not significant as a predictor for the occurrence of 
future stroke event, except atrial fibrillation episode (HR 13.4; p<0.005) 
that was encountered during hospitalization in the setting of AMI.
Conclusion. In-hospital AF in STEMI patients treated with thrombolytic 
agent is a predictor of long term stroke.
(J Kardiol Indones. 2011;32:223-8)
Keywords: Acute Myocardial Infarction, Stroke, Atrial Fibrillation
Department of Cardiology and 
Vascular Medicine, Faculty of Medi-
cine, University of Indonesia, and 







J Kardiol Indones. 2011;32:223-8
ISSN 0126/3773
Jurnal Kardiologi Indonesia •  Vol. 32, No. 4 • Oktober - Desember 2011
Atrial fibrillation (AF) is the common sustained 
arrhythmia in the general population with about 
1­2% prevalence and 0.1­0.2% annual incidence. 
The frequency of AF increases markedly with age 
and in octogenarians.1, 2The annual prevalence and 
incidence of AF are reported to be greater than 6 
and 2% respectively. As AF leads to the formation of 
Latar belakang. Fibrilasi atrium (AF) merupakan aritmia yang sering terjadi setelah infarct miokard akut (IMA). Mortalitas 
pada pasien IMA dengan AF meningkat dua kali lipat. Stroke non hemoragik terjadi pada 0.1 hingga 1.3% pasien IMA yang 
mendapat trombolitik. Tujuan penelitian ini untuk melihat korelasi antara AF selama perawatan IMA Elevasi Segmen ST 
(IMAEST) dengan kejadian stroke.
Metoda. Studi kohort retrospektif terhadap 230 pasien IMAEST yang mendapat terapi trombolitik. Kejadian serebro­
kardiovaskular mayor (KSKM) dicatat dalam masa pengamatan 3 tahun.
Hasil. Sebelas pasien mengalami AF dalam perawatan. Dua puluh empat (10.4%) pasien mengalami KSKM yaitu kematian 
jantung 4 (1.7%), infark yang fatal 2 (0.9%), infark non fatal 13 (5.7%) dan stroke 5 (2.2%). AF merupakan faktor risiko 
independenuntuk kejadian stroke (HR 13.4, p < 0.005).
Kesimpulan. AF selama perawatan IMA yang mendapat trombolitik merupakan prediktor stroke jangka panjang. 
(J Kardiol Indones. 2011;32:223­8)
Kata kunci: Infark miokard akut, stroke, fibrilasi atrial
Fibrilasi Atrial Selama Perawatan Infark 
Miokard Akut Merupakan Prediktor Stroke 
Jangka Panjang
Manoefris Kasim, Octavia Lilyasari, Yoga Yuniadi
thrombus in the left atrium, especially its appendage, 
individuals with AF have significant sixfold increase 
in their risk of ischaemic stroke and systemic 
cardioembolism when compared with those subjects 
with normal sinus rhythm.AF increases incidence 
of stroke independently of other important vascular 
risk factor such as hypertension, hyperlipidemia, 
and diabetes mellitus. AF is a common arrhythmia 
after acute myocardial infarction (MI), with reported 
incidence in previous studies between 5% and 23%. 
Atrial Fibrillation may have been pre­existing before 
acute MI or developed acutely following acute MI due 
to ischemia of the sinus node or atrial myocardium, or 
sub acutely following the development of congestive 
heart failure or pericarditis. Mortality in acute MI 
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patients with AF also been shown to be up to twice as 
high as for those without AF. 
Stroke is one of the most feared complications 
in patients withacute myocardial infarction. In the 
era before the routine useof thrombolytic therapy 
and anticoagulation, stroke was observedin 1.7% 
to 3.2% of patients. Intracranial hemorrhagewas 
exceedingly rare. In the thrombolytic era, the overall 
incidenceof stroke in large clinical trials is lower, but 
the types of strokeshave changed. Nonhemorrhagic 
stroke now occurs in 0.1% to 1.3% of patients, and 
intracranial hemorrhage occurs in 0.07% to1.5% 
of patientswho are treatedwith thrombolytic, with 
substantial associated mortality andmorbidity.
However, the mechanisms behind strokes related 
MIare not clear.3­6
Less is known about the risk factors for non­
hemorrhagicstroke in patients with acute myocardial 
infarction treated with thrombolytic therapy,7 although 
several investigators have reported clinical and 
echocardiographic factors associated withan increased 
risk for non­hemorrhagic stroke.8
The aim of this study is to examine the incidenceof 
Major Cardio­Cerebrovascular Event (MACCE) 
during 3 years after an acute myocardial infarction in 
patients who treated with thrombolytic therapy and 
to identify the predictors of myocardial infarction 
related stroke.
Methods 
This is a retrospective cohort longitudinal study. 
Patients were enrolled based on registry of acute 
myocardial infarction at the National Cardiovascular 
Center Harapan Kita (NCCHK) hospital, during 
the period of January 1997 until June 1999 and were 
observed and followed up until January 2000. 
The criteria for the diagnosis of acute MI were 
standardized and were identical for all participating 
hospital using the World Health Organization (WHO) 
criteria. A diagnosis of myocardial infarction was based 
on typical chest pain, electrocardiographic findings 
and a diagnostic elevation of cardiac enzymes. Two of 
three criteria were required.
All the participants were received thrombolytic 
therapy.
In brief, patients presenting with acute myocardial­
infarction within 12 hours of symptom onset were 
given intravenous 1.5 million units streptokinase 
over 1 hour and continue with intravenous heparin or 
unfractionated heparin for 5 days. All patients received 
aspirin (80­160 mg) daily.
The WHO definition of stroke was used: rapidly 
developing clinical sign of focal (or global) disturbance 
of cerebral function lasting more than 24 hours (unless 
interrupted by surgery or death) with no apparent 
cause other than a vascular origin.
All clinical variables were recorded from medical 
record file, such as age, sex, risk factors, laboratory 
data, electrocardiography (ECG) recording and other 
variables during hospitalization such as drug treatment 
of the acute MI, progression of angina, recurrent 
infarction, arrhythmias, and heart failure. After 
discharged the patients were monitored and followed 
up for the end points of cardiac related death, fatal 
and non­fatal MI, and fatal and non­fatal stroke. All 
clinical variables and hospitalization variables were 
tested to dependent variable stroke event. 
Statistical analysis
Group data are expressed as mean + standarddeviation 
(SD) for continuous variable and as count (percentage) 
for nominal variable. Differences between proportions 
were analyzed withnon­parametric test. The risk of 
MI­related stroke associated with different clinical 
characteristics is given by Odds Ratio (OR) with 
confidence interval (CI) 95%. Variable associated 
with a risk for MI­related stroke in univariate analysis 
or considered to be of potential clinical interest were 
included in the model. Kaplan Meir survival curves 
were calculated for patients with and without MI­
related stroke and compared between groups with the 
log rank test. The Cox proportional hazards model was 
used to identify predictors of stroke event. Data were 
analyzed with SPSS version 11.5. The p value of<0.05 
considered as statistically significant.
Results
During period of January 1997 up to June 1999,  230 
Acute ST elevation Myocardial Infarction patients 
aged 27­72 yearstreated with thrombolytic therapy 
were included in this study. Mean follow up time 
was 33.67 + 7.8 months (range of 1­42 months). 
Six subjects (2.6%) were lost tofollow up. Atrial 
fibrillation was occurred in 11 (4.78%) patients. 
Clinical characteristics and clinical finding during 
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including 2 patients (0.9%) with fatal infarction; 13 
patients (5.7%) had non­fatal MI, and stroke was 
occurred in 5 patients (2.2%). Stroke event ratewas 
18.18% in AF group and  1.37% in Non AF group 
(p<0.001) (figure 1). Annual stroke event rate in AF 
group was 4 %. 
the hospital stay of the two groups are compared in 
table 1. There were no significant differences between 
two groups in term of baseline characteristics of study 
population.
Total MACCE during follow up period was 24 
patients (10.4%). Four patients (1.7%) were dead 














































































Data were presented as count (percentage)
Table 2. Univariate Analysis































Table 3. Multivariate analysis
Variable HR (CI 95%) p
AF








Figure1. Cummulative hazard of stroke event among post­
acute MI patients treated with thrombolytic therapy.
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Univariate and multivariate analysis (table 2 and 
table 3) showed that the occurrence of AF during 
hospitalization significantly increase the risk of stroke 
event with HR 13.8 (CI 95% 2.3­82.4).AF was 
identified as independent predictors of stroke event 
in the present study.
Discussion
This study find that in­hospital AF of acute MI patient 
is an independent predictor of non­hemorragic stroke 
during mean follow­up of 33 months. 
This finding supports previous findings that 
showed patients with AF also had a higher likelihood 
of non­hemorrhagic strokethan patients who never 
experiencedAF/atrial flutter duringthe hospital 
stay.
Stroke after an acute MI is an infrequent but 
important clinical problem. The incidence of MI­
related stroke has been estimated in several studies 
both before and after introduction of aspirin and 
thrombolytic as standard therapy. Previous study found 
that stroke event rate after an acute MI that treated 
with thrombolytic therapy was 2.2%.3
This study revealed relatively low incidence of 
AF (4.78%) in acute MI patients. The incidence of 
AF in patients with acute MIvary depending on the 
population sampled. In the Cooperative Cardiovascular 
Project, 22% of Medicare beneficiaries65 y or older 
hospitalized for acute MI had AF.9 Lower rates of 
AF were observed in patients selected for other 
prospective trials, such as the Global Utilization of 
Streptokinase and Tissue Plasminogen Activator for 
Occluded Coronary Arteries (GUSTO­I) study, in 
which the incidence was 10.4%,10 but this may reflect 
the youngerage of patients presenting with acute MI 
associated with ST­segment elevation on the ECG. 
In our study most of subject aged less than 60 years 
old which support the previous study. AF is more 
commonly associated with acute MI in older patients 
and those withhigher Killip class or LV dysfunction.
AF is associated with increased in­hospital mortality 
in thesetting of acute MI (25.3% with AF vs. 16.0% 
without AF),30­d mortality (29.3% vs. 19.1%), 
and 1­y mortality (48.3%vs. 32.7%).9 Patients who 
developed AF during hospitalizationhad a worse 
prognosis than those with AF onadmission.9 Stroke 
rates are also increased in patientswith MI and AF 
compared with those without AF.10
The present study has several limitations. All the 
AF patients were pooled together as a single category 
without classification of paroxysmal, persistent, or 
permanent AF. The mechanism of non­hemorrhagic 
stroke was not determined, and some strokes may not 
have been related to cardiac events or procedures. Because 
of echocardiography was not mandated by this study 
protocol, the incidence of left ventricular thrombusin this 
study is unknown. Finally, these results are only applicable 
to the patients with acute myocardial infarction treated 
with thrombolytic therapy and should not be generalized 
to all patients with acute myocardial infarction.
Conclusion
AF episode during hospitalization in patients with 
acute MI is strongly related to the occurrence of stroke. 
This finding emphasis that AF should be recorded 
and taken into account as a marker of poor prognosis.
Further study to seek efficacy of medical intervention 
with anti­arrhythmic drugs and/or anticoagulant/
antiplatelet therapy as a secondary prevention of stroke 
event in the future.
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